Premium
Protocol consisting of cisplatin, etoposide and irinotecan induced complete pathological remission of primary small cell carcinoma of the bladder
Author(s) -
KAWAHARA TAKASHI,
NISHIYAMA HIROYUKI,
YAMAMOTO SHINGO,
KAMOTO TOSHIYUKI,
OGAWA OSAMU
Publication year - 2006
Publication title -
international journal of urology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.172
H-Index - 67
eISSN - 1442-2042
pISSN - 0919-8172
DOI - 10.1111/j.1442-2042.2006.01521.x
Subject(s) - medicine , etoposide , irinotecan , cystectomy , cisplatin , chemotherapy , pathological , oncology , carcinoma , urology , complete remission , bladder cancer , cancer , colorectal cancer
A 73‐year‐old man with primary small‐cell carcinoma of the bladder was treated by radical cystectomy with neoadjuvant chemotherapy. Pathological complete remission was achieved by combination chemotherapy composed of cisplatin, etoposide and irinotecan. The patient is free of disease 19 months after surgery.